STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow STE
STERIS plc (STE) EPS (diluted)
STERIS plc's EPS (diluted) for fiscal 2026 was $7.93, up 27.9% from $6.20 in fiscal 2025. Over the twelve months to 30 June 2026 it was $8.18. Over the past ten years it has ranged from $1.07 (fiscal 2023) to $7.93 (fiscal 2026) — the current reading is the highest in ten years. EPS (diluted) has risen for 3 consecutive fiscal years. STERIS plc ranks 8th of 147 Medical Devices companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $7.93 | 27.90% |
| FY2025 | $6.20 | 62.73% |
| FY2024 | $3.81 | 256.07% |
| FY2023 | $1.07 | (56.85%) |
| FY2022 | $2.48 | (46.44%) |
| FY2021 | $4.63 | (2.73%) |
| FY2020 | $4.76 | 33.71% |
| FY2019 | $3.56 | 5.01% |
| FY2018 | $3.39 | 164.84% |
| FY2017 | $1.28 | (17.95%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $2.04 | (8.93%) |
| Mar 2026 | $2.24 | 14.29% |
| Dec 2025 | $1.96 | 1.03% |
| Sep 2025 | $1.94 | 8.38% |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| BIO.B Bio-Rad Laboratories, Inc. compare | $8.25 |
| STE STERIS plc | $8.18 |
| GEHC GE HealthCare Technologies Inc. compare | $4.36 |
| ZBH Zimmer Biomet Holdings, Inc. compare | $4.11 |
| PEN Penumbra, Inc. compare | $4.07 |
| GMED Globus Medical, Inc. compare | $3.91 |
| DXCM DexCom, Inc. compare | $2.53 |
| PHG Koninklijke Philips N.V. compare | $1.36 |
| SNN Smith & Nephew SNATS, Inc. compare | $1.13 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement